Physician

Larisa Kayserman, MD

According to 2025 Medicare claims, Larisa Kayserman, MD (NPI: 1417926361) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is RETINA CONSULTANTS, PA, II (NPI: 1215906169; TIN: 223608319) and primary practice location at 07450-4451.

Kayserman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,599 traditional Medicare patients, billed 35,470 HCPCS/CPT codes, and received $3,914,100 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 852 prescription claims across 223 beneficiaries totaling $122,461 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 13 records totaling $894. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,613	20,550	$2,697,079
2016	1,416	17,709	$2,821,167
2017	1,563	17,773	$2,791,722
2018	1,700	18,074	$2,991,826
2019	1,417	15,858	$2,896,490
2020	1,241	12,741	$3,050,260
2021	1,314	13,770	$3,240,373
2022	1,350	13,891	$3,176,030
2023	1,475	22,809	$3,252,363
2024	1,599	35,470	$3,914,100

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	219	810	$125,310
2016	210	838	$134,483
2017	237	867	$164,073
2018	299	1,162	$211,578
2019	262	1,036	$200,236
2020	223	909	$185,070
2021	226	875	$148,254
2022	200	798	$131,985
2023	229	861	$137,282
2024	223	852	$122,461

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	356	1,880	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,102	1,571	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	394	522	$73
92134	Imaging of retina	1,524	3,713	$33
92201	Extended exam of the back part of the eye with retinal drawing	1,284	2,022	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolensa	Bromfenac Sodium	57	1,708	$21,071
Lumigan	Bimatoprost	35	2,116	$15,954
Restasis	Cyclosporine	15	735	$15,142
Bromfenac Sodium	Bromfenac Sodium	92	2,247	$12,300
Restasis Multidose	Cyclosporine	12	588	$12,001

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$894	Apellis Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Larisa Kayserman, MD?

Tedicare shows public-source Medicare data for Larisa Kayserman, MD (NPI 1417926361), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Larisa Kayserman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Larisa Kayserman, MD?

Larisa Kayserman, MD is linked to RETINA CONSULTANTS, PA, II (billing NPI 1215906169) in the available physician profile data.

Does Larisa Kayserman, MD have Open Payments data?

Larisa Kayserman, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.